These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2521967)

  • 1. [Effect of prodigiozan on the antibody-dependent cytotoxicity of neutrophils in chronic myeloid leukemia].
    Guseva SA; Tishchenko LM
    Vopr Onkol; 1989; 35(1):30-4. PubMed ID: 2521967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibody-dependent cell-mediated cytotoxicity of peripheral blood neutrophils in vitro in acute leukemia].
    Guseva SA
    Tsitologiia; 1985 Sep; 27(9):1067-70. PubMed ID: 2997955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
    Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
    Cordier G; Samarut C; Revillard JP
    Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha-interferon on MHC unrestricted cytotoxicity in chronic myelogenous leukemia.
    Meseri-Delwail A; Delwail V; Brizard A; Goube de Laforest P; Guilhot F; Lecron JC
    Biotechnol Ther; 1994; 5(1-2):47-57. PubMed ID: 7703832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prodigiozan treatment of patients with acute myeloblastic leukemia].
    Tishchenko LM; Guseva SA
    Vrach Delo; 1987 Jan; (1):69-72. PubMed ID: 3471004
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prodigiozan in the therapy of destructive pulmonary tuberculosis].
    Kornilova ZKh; Svitneva AS
    Probl Tuberk; 1980 Jan; (1):30-2. PubMed ID: 7367422
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards combination target-directed chemotherapy for chronic myeloid leukemia: role of farnesyl transferase inhibitors.
    Daley GQ
    Semin Hematol; 2003 Apr; 40(2 Suppl 2):11-4. PubMed ID: 12783369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cellular cytotoxicity of leukaemic blast cells and neutrophils from patients with acute myelogenous leukaemia.
    Dallegri F; Holm G; Gahrton G
    Clin Exp Immunol; 1982 Feb; 47(2):414-8. PubMed ID: 6951665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.
    Fruehauf S; Topaly J; Buss EC; Fischer T; Ottmann OG; Emmerich B; Müller MC; Schuld P; Balleisen L; Hehlmann R; Ho AD; Hochhaus A
    Cancer; 2007 Apr; 109(8):1543-9. PubMed ID: 17340589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of prodigiozan in the overall treatment of pulmonary tuberculosis in children and adolescents].
    Kshanovskiĭ SA; Rushchak VA; Tsymbaliuk GF; Kostromina VP; Medvedeva MM
    Probl Tuberk; 1980 Jan; (1):33-6. PubMed ID: 6966060
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative assessment of pathogenic agents in the combined treatment of respiratory organ tuberculosis].
    Karapetian ET; Markova EF; Gasparian AA; Apresian EA; Saakian AL
    Probl Tuberk; 1982 Mar; (3):40-4. PubMed ID: 7088922
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G; Weber G
    Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic leukemia].
    Shibata A; Narita M
    Gan To Kagaku Ryoho; 1989 May; 16(5):1982-8. PubMed ID: 2658837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of comprehensive antibacterial therapy in combination with prodigiozan on energy metabolic indices in children and adolescents with pulmonary tuberculosis].
    Kshanovs'kyĭ SA; Rushchak VA; Maliuk VI; Vel'tman RV; Polner RA
    Pediatr Akus Ginekol; 1979; (3):16-8. PubMed ID: 379787
    [No Abstract]   [Full Text] [Related]  

  • 17. Splenomegaly and hepatomegaly at onset of blastic crisis in chronic myeloid leukaemia have prognostic importance.
    Parikh PM; Charak BS; Banavali SD; Koppikar SB; Giri NK; Kumar A; Saikia TK; Gopal R; Mazumdar AT; Advani SH
    J Assoc Physicians India; 1988 Nov; 36(11):653-5. PubMed ID: 3248993
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia.
    Li Z; Qiao Y; Liu B; Laska EJ; Chakravarthi P; Kulko JM; Bona RD; Fang M; Hegde U; Moyo V; Tannenbaum SH; Ménoret A; Gaffney J; Glynn L; Runowicz CD; Srivastava PK
    Clin Cancer Res; 2005 Jun; 11(12):4460-8. PubMed ID: 15958631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of prodigiozan in the combined therapy of infectious diseases (a review of the literature)].
    Frolov VM; Rychnev VE
    Vrach Delo; 1986 Feb; (2):111-4. PubMed ID: 3518241
    [No Abstract]   [Full Text] [Related]  

  • 20. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
    Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
    Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.